Literature DB >> 17678555

Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease.

E Vynnycky1, M W Borgdorff, C C Leung, C M Tam, P E M Fine.   

Abstract

Over 50% of the global burden of tuberculosis occurs in South East Asia and the Western Pacific. Since 1950, notification rates in high-income countries in these settings have declined slowly and have remained over ten-fold greater than those in Western populations. The reasons for the slow decline are poorly understood. Using an age-structured model describing the incidence of Mycobacterium tuberculosis infection and disease applied to notification data from Hong Kong, we illustrate that in Hong Kong, a high prevalence of M. tuberculosis infection among older individuals and a high risk of disease through reactivation (e.g. up to 17-fold greater than that estimated for infected males in the United Kingdom) may explain this slow decline. If this feature of the epidemiology of tuberculosis is widespread, the WHO directly observed treatment short-course (DOTS) strategy may have a smaller impact in Asia in the short term than has been implied by recent predictions, all of which have been based on disease risk estimates derived from Western Europe. As a result, it may be difficult to meet the targets for tuberculosis control, which have been prescribed by the UN Millennium Development Goals.

Entities:  

Mesh:

Year:  2007        PMID: 17678555      PMCID: PMC2870882          DOI: 10.1017/S0950268807008552

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  TUBERCULOSIS IN HONG KONG.

Authors:  A S MOODIE
Journal:  Tubercle       Date:  1963-09

2.  Decline of the tuberculosis epidemic in Alaska.

Authors:  G W COMSTOCK; R N PHILIP
Journal:  Public Health Rep       Date:  1961-01       Impact factor: 2.792

3.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

4.  Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales.

Authors:  K Tocque; M A Bellis; C M Tam; S L Chan; Q Syed; T Remmington; P D Davies
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

5.  Effects of strong government measures against tobacco in Hong Kong.

Authors:  J M Mackay; G T Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-31

6.  Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1995-08-11

7.  The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.

Authors:  E Vynnycky; P E Fine
Journal:  Epidemiol Infect       Date:  1997-10       Impact factor: 2.451

8.  Tuberculosis risk factors in a silicotic cohort in Hong Kong.

Authors:  K C Chang; C C Leung; C M Tam
Journal:  Int J Tuberc Lung Dis       Date:  2001-02       Impact factor: 2.373

9.  Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy.

Authors:  N T Huong; B D Duong; N V Co; H T Quy; L B Tung; J F Broekmans; M C Bosman; C Verhage; N Kalisvaart; M W Borgdorff; F G Cobelens
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

10.  The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901.

Authors:  E Vynnycky; P E Fine
Journal:  Int J Tuberc Lung Dis       Date:  1997-10       Impact factor: 2.373

View more
  21 in total

1.  How host heterogeneity governs tuberculosis reinfection?

Authors:  M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

Review 2.  Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

Authors:  D W Dowdy; C Dye; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-07       Impact factor: 2.373

Review 3.  The impact of migration on tuberculosis in the United States.

Authors:  N A Menzies; A N Hill; T Cohen; J A Salomon
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

4.  The transmission dynamics of tuberculosis in a recently developed Chinese city.

Authors:  Peng Wu; Eric H Y Lau; Benjamin J Cowling; Chi-Chiu Leung; Cheuk-Ming Tam; Gabriel M Leung
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

5.  Distribution of molecular strains of Mycobacterium tuberculosis in an intermediate burden Asia Pacific city.

Authors:  Shui Shan Lee; Denise Pui Chung Chan; Ngai Sze Wong; Grace Chung Yan Lui; Kin Wang To; Joseph Kai Man Kam
Journal:  Epidemiol Infect       Date:  2021-05-19       Impact factor: 2.451

6.  Nutrition, diabetes and tuberculosis in the epidemiological transition.

Authors:  Christopher Dye; Bernadette Bourdin Trunz; Knut Lönnroth; Gojka Roglic; Brian G Williams
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

7.  Periodic active case finding for TB: when to look?

Authors:  Peter J Dodd; Richard G White; Elizabeth L Corbett
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

8.  The impact of realistic age structure in simple models of tuberculosis transmission.

Authors:  Ellen Brooks-Pollock; Ted Cohen; Megan Murray
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

9.  Info-gap management of public health Policy for TB with HIV-prevalence and epidemiological uncertainty.

Authors:  Yakov Ben-Haim; Clifford C Dacso; Nicola M Zetola
Journal:  BMC Public Health       Date:  2012-12-19       Impact factor: 3.295

10.  Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010.

Authors:  Young Kil Park; Yoon-Sung Park; Kyoung In Na; En Hi Cho; Sang-Sook Shin; Hee Jin Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.